331 related articles for article (PubMed ID: 16330163)
1. Rationale and perspectives on the success of vaccination against bovine herpesvirus-1.
van Drunen Littel-van den Hurk S
Vet Microbiol; 2006 Mar; 113(3-4):275-82. PubMed ID: 16330163
[TBL] [Abstract][Full Text] [Related]
2. A live bovine herpesvirus-1 marker vaccine is not shed after intramuscular vaccination.
Makoschey B; Beer M
Berl Munch Tierarztl Wochenschr; 2007; 120(11-12):480-2. PubMed ID: 18085158
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge.
Silva AD; Spilki FR; Franco AC; Esteves PA; Hübner SO; Driemeier D; Oliveira AP; Rijsewijk F; Roehe PM
Vaccine; 2006 Apr; 24(16):3313-20. PubMed ID: 16480790
[TBL] [Abstract][Full Text] [Related]
4. Cell-mediated immune responses induced by BHV-1: rational vaccine design.
van Drunen Littel-van den Hurk S
Expert Rev Vaccines; 2007 Jun; 6(3):369-80. PubMed ID: 17542752
[TBL] [Abstract][Full Text] [Related]
5. [Conventional and marked BHV-1 vaccines in Germany: a brief review].
Trapp S; König P; Beer M
Berl Munch Tierarztl Wochenschr; 2003; 116(5-6):208-15. PubMed ID: 12784554
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of a temperature-sensitive modified-live bovine herpesvirus type-1 vaccine against abortion and stillbirth in pregnant heifers.
Cravens RL; Ellsworth MA; Sorensen CD; White AK
J Am Vet Med Assoc; 1996 Jun; 208(12):2031-4. PubMed ID: 8707679
[TBL] [Abstract][Full Text] [Related]
7. Infectious bovine rhinotracheitis: study on the experimentally induced disease and its prevention using an inactivated, adjuvanted vaccine.
Soulebot JP; Guillemin F; Brun A; Dubourget P; Espinasse J; Terre J
Dev Biol Stand; 1982; 52():463-83. PubMed ID: 6299856
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the efficacy of a modified-live combination vaccine against abortion caused by virulent bovine herpesvirus type 1 in a one-year duration-of-immunity study.
Ficken MD; Ellsworth MA; Tucker CM
Vet Ther; 2006; 7(3):275-82. PubMed ID: 17039450
[TBL] [Abstract][Full Text] [Related]
9. Partial protection induced by a BHV-1 recombinant vaccine against challenge with BHV-5.
Spilki FR; Silva AD; Hübner S; Esteves PA; Franco AC; Driemeier D; Roehe PM
Ann N Y Acad Sci; 2004 Oct; 1026():247-50. PubMed ID: 15604501
[TBL] [Abstract][Full Text] [Related]
10. Rapid onset of protection following vaccination of calves with multivalent vaccines containing modified-live or modified-live and killed BHV-1 is associated with virus-specific interferon gamma production.
Woolums AR; Siger L; Johnson S; Gallo G; Conlon J
Vaccine; 2003 Mar; 21(11-12):1158-64. PubMed ID: 12559793
[TBL] [Abstract][Full Text] [Related]
11. Effect of vaccination against bovine herpesvirus 1 with inactivated gE-negative marker vaccines on the health of dairy cattle herds.
Raaperi K; Orro T; Viltrop A
Prev Vet Med; 2015 Mar; 118(4):467-76. PubMed ID: 25662288
[TBL] [Abstract][Full Text] [Related]
12. The use of marker vaccines in eradication of herpesviruses.
van Oirschot JT; Kaashoek MJ; Rijsewijk FA; Stegeman JA
J Biotechnol; 1996 Jan; 44(1-3):75-81. PubMed ID: 8717389
[TBL] [Abstract][Full Text] [Related]
13. Strategies for induction of protective immunity to bovine herpesvirus-1 in newborn calves with maternal antibodies.
van Drunen Littel-van den Hurk S; Snider M; Thompson P; Latimer L; Babiuk LA
Vaccine; 2008 Jun; 26(25):3103-11. PubMed ID: 18433948
[TBL] [Abstract][Full Text] [Related]
14. A combined bovine herpesvirus 1 gB-gD DNA vaccine induces immune response in mice.
Caselli E; Boni M; Di Luca D; Salvatori D; Vita A; Cassai E
Comp Immunol Microbiol Infect Dis; 2005 Mar; 28(2):155-66. PubMed ID: 15582691
[TBL] [Abstract][Full Text] [Related]
15. Safety aspects in the development of an infectious bovine rhinotracheitis marker vaccine.
Strube W; Abar B; Bergle RD; Block W; Heinen E; Kretzdorn D; Rodenbach C; Schmeer N
Dev Biol Stand; 1995; 84():75-81. PubMed ID: 7796970
[TBL] [Abstract][Full Text] [Related]
16. Induction of antigen-specific T-cell subset activation to bovine respiratory disease viruses by a modified-live virus vaccine.
Platt R; Burdett W; Roth JA
Am J Vet Res; 2006 Jul; 67(7):1179-84. PubMed ID: 16817740
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of symptoms associated with bovine herpesvirus 1 vaccination].
van Wuijckhuise L; Frankena K; van Oijen MA; Meijer L
Tijdschr Diergeneeskd; 2001 Mar; 126(6):173-80. PubMed ID: 11285635
[TBL] [Abstract][Full Text] [Related]
18. Prime-boost strategies combining DNA and inactivated vaccines confer high immunity and protection in cattle against bovine herpesvirus-1.
Toussaint JF; Letellier C; Paquet D; Dispas M; Kerkhofs P
Vaccine; 2005 Oct; 23(43):5073-81. PubMed ID: 16024138
[TBL] [Abstract][Full Text] [Related]
19. BHV-1 vaccine induces cross-protection against BHV-5 disease in cattle.
Del Médico Zajac MP; Puntel M; Zamorano PI; Sadir AM; Romera SA
Res Vet Sci; 2006 Dec; 81(3):327-34. PubMed ID: 16540133
[TBL] [Abstract][Full Text] [Related]
20. [Diagnostic markers in the prevention of bovine herpesvirus type 1: possibilities and limitations].
Beer M; König P; Schielke G; Trapp S
Berl Munch Tierarztl Wochenschr; 2003; 116(5-6):183-91. PubMed ID: 12784550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
